Karius is a company based in the United States, founded in 2014, that operates within the Business Services industry, specifically focusing on research and development in the biotech and pharmaceuticals sectors. With a workforce ranging from 51 to 200 employees, Karius has established itself in the field of diagnostic applications. The company has published a document titled "FUO_Diagnostic_Application_for_Karius_Test," which appears to be a case study related to its diagnostic testing capabilities. This document outlines the application of Karius tests in the context of fever of unknown origin (FUO), indicating the company's commitment to addressing complex medical challenges through innovative diagnostic solutions. Karius's work is situated at the intersection of biotechnology and healthcare, reflecting its role in advancing diagnostic methodologies within the medical community. The company reported revenue of approximately $10.57 million, highlighting its operational scale within the competitive biotech landscape. Overall, Karius is positioned as a contributor to the development of diagnostic tools that support clinical decision-making in the healthcare sector.